These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31935339)

  • 1. Increasing Antipsychotic Dose Versus Switching Antipsychotic for Non Response in Schizophrenia.
    Pich J
    Issues Ment Health Nurs; 2020 Apr; 41(4):373-374. PubMed ID: 31935339
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching.
    Agid O; Schulze L; Arenovich T; Sajeev G; McDonald K; Foussias G; Fervaha G; Remington G
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1017-22. PubMed ID: 23706529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis.
    Takeuchi H; Kantor N; Uchida H; Suzuki T; Remington G
    Schizophr Bull; 2017 Jul; 43(4):862-871. PubMed ID: 28044008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of aripiprazole once-monthly in patients with schizophrenia.
    Raoufinia A; Baker RA; Eramo A; Nylander AG; Landsberg W; Kostic D; Larsen F
    Curr Med Res Opin; 2015 Mar; 31(3):583-92. PubMed ID: 25586294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic Olanzapine Substitution in Patients With Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching.
    Italiano D; Bruno A; Santoro V; Lanza G; Muscatello MR; Zoccali R; Spina E
    Ther Drug Monit; 2015 Dec; 37(6):827-30. PubMed ID: 25830930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.
    Martínez-Andrés JA; García-Carmona JA
    Int Clin Psychopharmacol; 2020 May; 35(3):163-169. PubMed ID: 31851035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
    Rossi A; Cañas F; Fagiolini A; Larmo I; Levy P; Montes JM; Papageorgiou G; Sturlason R; Zink M; Correll CU
    Postgrad Med; 2011 Jan; 123(1):135-59. PubMed ID: 21293094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    Mukundan A; Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD006629. PubMed ID: 21154372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gradual vs. wait-and-gradual discontinuation in antipsychotic switching: A meta-analysis.
    Takeuchi H; Thiyanavadivel S; Agid O; Remington G
    Schizophr Res; 2017 Nov; 189():4-8. PubMed ID: 28242107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective Switch From Clozapine to Aripiprazole in Treatment-Resistant Schizophrenia and Comorbid Alcohol Use Disorder.
    Feeley RJ; Arnaout B; Yoon G
    J Clin Psychopharmacol; 2017 Dec; 37(6):729-730. PubMed ID: 29028689
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of sexual adverse effects induced by atypical antipsychotic medication.
    Downing L; Kim DD; Procyshyn RM`; Tibbo P
    J Psychiatry Neurosci; 2019 Jul; 44(4):287-288. PubMed ID: 31245972
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine, a controversial gold standard antipsychotic for the 21st century: Switching to paliperidone palmitate 3-monthly improves the metabolic profile and lowers antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.
    Martínez-Andrés JA; García-Carmona JA
    Schizophr Res; 2019 Oct; 212():234-236. PubMed ID: 31421972
    [No Abstract]   [Full Text] [Related]  

  • 13. The art and science of switching of antipsychotic medications, part 1.
    Weiden PJ; Young AH; Buckley PF
    J Clin Psychiatry; 2006 Nov; 67(11):e15. PubMed ID: 17201045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Switching to monotherapy and optimization of drug therapy for long-term hospitalized patients and chronically sick patients].
    Hirao T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1041-7. PubMed ID: 22187892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simplification and optimization in drug therapy for patients with schizophrenia--knowledge and techniques in drug switching].
    Takeda T
    Seishin Shinkeigaku Zasshi; 2006; 108(6):624-30. PubMed ID: 16910541
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation.
    Loebel A; Citrome L; Correll CU; Xu J; Cucchiaro J; Kane JM
    BMC Psychiatry; 2015 Oct; 15():271. PubMed ID: 26521019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial.
    Cheng Z; Yuan Y; Han X; Yang L; Zeng X; Yang F; Lu Z; Wang C; Deng H; Zhao J; Xiang YT; Correll CU; Yu X
    Psychiatry Res; 2019 Mar; 273():631-640. PubMed ID: 30735922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
    Hatta K; Otachi T; Fujita K; Morikawa F; Ito S; Tomiyama H; Abe T; Sudo Y; Takebayashi H; Yamashita T; Katayama S; Nakase R; Shirai Y; Usui C; Nakamura H; Ito H; Hirata T; Sawa Y;
    Schizophr Res; 2014 Sep; 158(1-3):213-22. PubMed ID: 25086659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Original research paper. Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders.
    Bole CB; Pišlar M; Šen M; Tavčar R; Mrhar A
    Acta Pharm; 2017 Mar; 67(1):99-112. PubMed ID: 28231044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.